Health IT Analytics January 5, 2022
The American Diabetes Association and Renalytix will collaborate to improve population health and chronic disease management for patients with type 2 diabetes.
To improve population health and chronic disease management, the American Diabetes Association and Renalytix have announced a joint program to enhance the overall kidney health of patients with type 2 diabetes in the United States.
Approximately 34.2 million Americans and an estimated 422 million people worldwide have diabetes. Type 2 diabetes is the most common type, making up 90 to 95 percent of all diabetes cases in adults.
Additionally, medical professionals now recognize kidney disease as a public health epidemic, impacting over 850 million individuals globally.
Today's Sponsors
Today's Sponsor